v3.25.2
Segment Information - Summary of Revenue by Segment and Reconciling Items (Details) - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2023
Segment Reporting Information [Line Items]      
Net revenue by segment $ 5,146,327 $ 4,685,297 $ 4,222,993
Cost of Sales 2,091,357 2,029,994 1,867,331
Selling, general, and administrative 991,019 917,136 874,003
Research and development 331,284 307,525 287,642
Net operating profit by segment 1,685,363 1,319,893 1,131,871
Amortization of acquired intangible assets 45,273 46,521 42,020
Restructuring expenses 0 64,228 9,177
Acquisition related expenses 2,031 0 10,949
Interest (income) expense, net 4,114 (45,708) (47,379)
(Gain) loss attributable to equity method investments 3,644 (1,848) (7,265)
(Gain) loss on equity investments (10,299) (4,045) 9,922
Gain on insurance recoveries 0 0 20,227
Other, net (5,256) (3,494) (5,712)
Income before income taxes 1,677,566 1,264,798 1,101,664
Depreciation and amortization by segment 198,473 176,870 165,156
Operating Segments      
Segment Reporting Information [Line Items]      
Cost of Sales 2,047,617 1,972,209 1,833,755
Selling, general, and administrative 635,026 595,333 563,950
Research and development 294,299 281,951 262,513
Net operating profit by segment 2,169,385 1,835,804 1,562,775
Reconciling items      
Segment Reporting Information [Line Items]      
Corporate costs 406,114 357,937 338,362
Amortization of acquired intangible assets 77,389 79,484 72,416
Restructuring expenses 0 64,228 9,177
Masks with magnets field safety notification expenses (1,512) 6,351 0
Astral field safety notification expenses 0 7,911 0
Acquisition related expenses 2,031 0 10,949
Interest (income) expense, net (4,114) 45,708 47,379
(Gain) loss attributable to equity method investments (3,644) 1,848 7,265
(Gain) loss on equity investments 10,299 4,045 (9,922)
Gain on insurance recoveries 0 0 (20,227)
Other, net 5,256 3,494 5,712
Income before income taxes 1,677,566 1,264,798 1,101,664
Corporate Costs      
Segment Reporting Information [Line Items]      
Depreciation and amortization by segment 78,463 80,559 73,493
Sleep and Breathing Health      
Segment Reporting Information [Line Items]      
Net revenue by segment 4,504,890 4,101,172 3,725,017
Sleep and Breathing Health | Operating Segments      
Segment Reporting Information [Line Items]      
Cost of Sales 1,852,574 1,782,023 1,659,037
Selling, general, and administrative 491,591 451,334 443,467
Research and development 196,340 186,461 175,393
Net operating profit by segment 1,964,385 1,681,354 1,447,120
Depreciation and amortization by segment 110,543 86,070 82,544
Residential Care Software      
Segment Reporting Information [Line Items]      
Net revenue by segment 641,437 584,125 497,976
Operating lease, impairment loss   4,100  
Residential Care Software | Operating Segments      
Segment Reporting Information [Line Items]      
Cost of Sales 195,043 190,186 174,718
Selling, general, and administrative 143,435 143,999 120,483
Research and development 97,959 95,490 87,120
Net operating profit by segment 205,000 154,450 115,655
Depreciation and amortization by segment $ 9,467 $ 10,241 $ 9,119